The IPO market is starting to feel healthier. Omada Health, a 14-year-old company providing virtual care for chronic conditions like diabetes and hypertension between office visits, closed its first trading day on Friday at $23 a share, a 21% jump from the IPO price of $19.

Omada Health is set to start trading on the Nasdaq, hitting the market a few weeks after Hinge Health, another emerging company in the space.

Virtual chronic care provider Omada Health said on Thursday it had raised $150 million in its U.S. initial public offering, another sign of recovering investor appetite for new stocks.

The significant surge in Circle’s first-day trading could prompt institutional investors to set higher IPO prices for upcoming listings. Imminent IPOs include Omada Health, which is pricing on Thursday, and Klarna, a fintech that’s set to list next week.

Venture capital's distribution blockade may be breaking down, at least a bit, thanks to some unicorns finally accepting that their ZIRP-era valuations were inflated. Driving the news: Circle and Omada Health both are expected to price IPOs this week,